Target- |
MechanismBacteria replacements [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
阴道用乳杆菌二联活菌胶囊治疗细菌性阴道病的多中心、随机、双盲、安慰剂对照的有效性和安全性Ⅲ期临床研究
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase III clinical study on the efficacy and safety of vaginal Lactobacillus dual-acti capsules in the treatment of bacterial vaginosis
验证阴道用乳杆菌二联活菌胶囊治疗细菌性阴道病临床治愈率优于安慰剂
[Translation] Verification of the clinical cure rate of vaginal Lactobacillus dual-acti capsules in the treatment of bacterial vaginosis is better than placebo
阴道用乳杆菌二联活菌胶囊治疗细菌性阴道病的多中心、随机、双盲、安慰剂对照的有效性和安全性临床研究
[Translation] A multicenter, randomized, double-blind, placebo-controlled clinical study on the efficacy and safety of vaginal Lactobacillus dual-acti capsules in the treatment of bacterial vaginosis
探索阴道用乳杆菌二联活菌胶囊14天治疗细菌性阴道病在临床治愈方面的有效性和安全性
[Translation] To explore the effectiveness and safety of vaginal Lactobacillus dual-acti capsules for 14 days in the treatment of bacterial vaginosis in clinical cure
阴道用乳杆菌二联活菌胶囊多次给药对细菌性阴道病患者的安全性、耐受性研究
[Translation] Study on the safety and tolerance of multiple administration of vaginal Lactobacillus dual-acti capsules in patients with bacterial vaginosis
评估阴道用乳杆菌二联活菌胶囊经阴道给药对细菌性阴道病患者的安全性、耐受性。
[Translation] To evaluate the safety and tolerability of vaginal Lactobacillus dual-bacterium live capsules in patients with bacterial vaginosis.
100 Clinical Results associated with Guangdong Longchuangji Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Guangdong Longchuangji Pharmaceutical Co., Ltd.
100 Deals associated with Guangdong Longchuangji Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Guangdong Longchuangji Pharmaceutical Co., Ltd.